Editorial Policy

MedCentralHub exists to make trustworthy medical reference content accessible to anyone who needs it. Our editorial policy is built on four principles:

• Authoritative sourcing. Every clinical claim is traceable to a published, authoritative source — primarily U.S. federal health agencies and peer-reviewed literature.
• Transparency. We disclose how content is produced, what data sources we use, when pages were last reviewed, and where automation is involved.
• Independence. Editorial decisions are not influenced by advertisers, sponsors, or commercial relationships. We do not accept paid product placement.
• Accountability. We publish corrections quickly when errors are identified and document the changes made.

MedCentralHub draws its core content from a curated set of authoritative, publicly available datasets. Our principal sources are:

• OpenFDA — FDA-approved drug labels (Structured Product Labeling), adverse event reports (FAERS), enforcement actions and recalls, NDC directory, and the Orange Book of approved therapeutic equivalents. This is our primary source for U.S. drug prescribing information.
• RxNorm — Standardized clinical drug nomenclature maintained by the National Library of Medicine, used to reliably map brand and generic names, dosage forms, strengths, and active ingredients.
• MedlinePlus — NIH consumer health content, drug information, health topics, and the medical encyclopedia. Used for plain-language framing and as a cross-check for patient-facing content.
• ICD-10-CM — Standard diagnostic coding used to align our condition taxonomy with international classification.
• CDC — Immunization schedules, infectious disease surveillance, travel health notices, and population-level epidemiology.
• NIH institutes — Including NCI, NHLBI, NIAID, NIMH, NIDDK, NIAMS, and others, whose patient-facing guidelines inform our condition pages.
• ClinicalTrials.gov — The public registry of clinical research, used for clinical-trial coverage and emerging-therapy content.
• Peer-reviewed literature — PubMed-indexed publications, professional society guidelines (e.g., ACC/AHA, ADA, IDSA, ACOG), and Cochrane systematic reviews, used to contextualize and expand on regulatory-label content.

Drug labels, recall notices, and clinical guidelines change frequently. Our update workflow is designed to keep MedCentralHub current without manual lag:

• Automated dataset re-pull every 30 days. Our build pipeline re-ingests OpenFDA, RxNorm, MedlinePlus, ICD-10, CDC, and NIH datasets on a rolling 30-day cycle. Updated labels, new approvals, and recalls flow into the site automatically.
• Monthly editorial review of high-traffic pages.The 100 most-visited drug and condition pages are reviewed each month for accuracy, clarity, and currency. The "Last reviewed" date is refreshed after each review.
• Quarterly review of secondary pages. The next tier of drug and condition pages — generally those with material traffic but not in the top 100 — is reviewed at least quarterly.
• Annual review of the remainder. Pages with low traffic but ongoing public value (rare disease pages, less common drugs) are reviewed at least once per year.
• Event-driven updates. When an FDA safety communication, black-box warning addition, recall, or major guideline change is announced, affected pages are updated promptly, typically within 72 hours of public release.

Every clinical claim on MedCentralHub passes through a multi-step verification process:

1. Source identification. Each statement is mapped to the authoritative source from which it derives — most commonly the FDA-approved label for the medication in question.
2. Cross-reference. Where multiple sources speak to the same point (e.g., FDA label vs. MedlinePlus consumer summary vs. society guideline), we cross-check for consistency and flag discrepancies for editorial review.
3. Editorial review. A team member with relevant clinical or pharmaceutical background reviews the draft for accuracy, clarity, and tone. Particularly sensitive content (dosing, pregnancy, pediatrics, controlled substances, oncology) receives an additional layer of review.
4. Publish with metadata.Pages are published with a "Last reviewed" date and a link to the underlying source where appropriate.
5. Post-publication monitoring. Reader-reported errors, internal audits, and the automated re-pull cycle continue to surface potential updates after a page is live.

We take corrections seriously. If you believe a page on MedCentralHubcontains an error, please email correction@medcentralhub.com with the page URL and a description of the issue. Where possible, include the authoritative source (FDA label section, peer-reviewed citation, guideline reference) that supports your correction.

We acknowledge correction emails within 2 business days. Substantive clinical corrections are evaluated by an editorial reviewer with relevant expertise and, where warranted, published within 5–10 business days. For corrections that materially change the meaning of previously published content, we note the change and the date at the bottom of the affected page.

Minor typographical or formatting fixes are made silently. Clinical content changes are dated and described.

Most pages on MedCentralHub are produced by the MedCentralHubEditorial Team — a collaborative effort spanning writers, software engineers, and clinicians. We publish under the team byline rather than individual bylines for most content because page content is the product of dataset ingestion plus editorial structuring rather than any single author's opinion piece.

Where individual contributors author substantive long-form pieces (educational guides, condition deep-dives, opinion or analysis), we attribute the byline by name and disclose relevant qualifications and any conflicts of interest. Reviewing clinicians, when used, are credited separately from authors.

The MedCentralHub Editorial Team does not have financial relationships with pharmaceutical manufacturers, medical device makers, insurers, or pharmacy chains. We do not accept payment, gifts, or other compensation in exchange for favorable coverage of any product, and we do not allow advertisers to influence editorial decisions.

The site is supported by display advertising served through standard ad networks (including Google AdSense). Ad placement is technically separated from editorial production; advertisers do not see or approve editorial content, and editors do not see advertiser identities when producing content. Sponsored or paid content, when published, is clearly labeled as such — but as of this writing, MedCentralHub does not publish sponsored content.

Individual contributors are required to disclose any potentially conflicting financial relationships (consulting, equity, employment) at the time they join the team and to update disclosures as situations change. Pages authored by an individual with a relevant disclosed relationship are reviewed by an unconflicted editor before publication.

MedCentralHub is built with a programmatic content pipeline. Drug and condition pages are assembled from authoritative public APIs (OpenFDA, RxNorm, MedlinePlus, ICD-10, CDC, NIH) using deterministic code — not large-language-model generation. The clinical facts on a drug page originate from the FDA-approved label or another cited source, mapped into a structured page by software the editorial team builds and maintains.

We do not use generative AI (such as ChatGPT, Claude, Gemini, or similar large language models) to write clinical content. We consider LLM-generated clinical text unreliable for the purposes of a medical reference site because such models can fabricate facts, hallucinate citations, and produce plausible-sounding inaccuracies that are difficult to detect at scale.

We may use automation for routine, non-clinical tasks: spell-checking, grammar review, accessibility audits, broken-link detection, schema validation, and similar housekeeping. Where any AI assistance has been used in producing prose on a page, we will say so on that page.

Aggregation, summarization, and structural transformations of the underlying public-domain data are programmatic but rule-based. The editorial team reviews and refines the templates that drive that programmatic assembly.

Trust in a medical reference is earned page by page. We commit to transparency about sources, currency, authorship, and automation; to acting promptly on corrections; and to keeping editorial decisions independent of commercial interests. We invite scrutiny and welcome feedback through our Contact page.

For the legal terms governing your use of the site, see our Terms of Service and Privacy Policy. For the limits of what this site can and cannot do for you medically, see our Medical Disclaimer.